New Covenant Trust Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,216
Closed -$258K 99
2025
Q4
$258K Sell
3,216
-127
-4% -$10K 0.23% 75
2025
Q3
$252K Sell
3,343
-79
-2% -$5.41K 0.23% 68
2025
Q2
$234K Hold
3,422
0.21% 74
2025
Q1
$230K Buy
+3,422
New +$205K 0.24% 79
2024
Q4
Sell
-4,170
Closed -$256K 92
2024
Q3
$256K Buy
4,170
+558
+15% +$32.6K 0.25% 72
2024
Q2
$215K Buy
3,612
+586
+19% +$36.7K 0.25% 71
2024
Q1
$241K Buy
+3,026
New +$231K 0.24% 67

Other funds holding CVS

New Covenant Trust Company's CVS Position: Q1 2026 in Review

New Covenant Trust Company sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,216 shares — an estimated $258K sold.

New Covenant Trust Company first reported a position in CVS in Q1 2024 and held it in 7 quarters. The position peaked at $258K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • New Covenant Trust Company reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • New Covenant Trust Company sold 3,216 CVS Health shares in Q1 2026, an estimated $258K.
  • New Covenant Trust Company first reported a position in CVS Health in Q1 2024 and held it in 7 quarters.
  • New Covenant Trust Company's CVS Health position peaked at $258K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on New Covenant Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.